Joost L.M. Jongen

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

Annemiek Broyl, Sophie L. Corthals, Joost L.M. Jongen et al. · The Lancet Oncology · 2010 · 220 citations

Hematological Malignancy, Neuro-oncology, Peripheral Neuropathy +8

Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.

Mary Ann C. Sabino, Joseph R. Ghilardi, Joost L.M. Jongen et al. · PubMed · 2002 · 200 citations

Pain Medicine, Osteoporosis, Tumor Biology +19

Pain in Guillain-Barré syndrome

Liselotte Ruts, Judith Drenthen, Joost L.M. Jongen et al. · Neurology · 2010 · 198 citations

Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.

Antoinetta J. M. Beijers, Joost L.M. Jongen, Gerard Vreugdenhil · PubMed · 2012 · 123 citations

Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors

Émilie Le Rhun, Patrick Devos, Johannes Weller et al. · Neuro-Oncology · 2020 · 112 citations · Full text